铁性碳酸在心脏手术后减少输血和感染

相关实验视频

Updated: Jun 3, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Tuomas O Kiviniemi^1,2, Vesa Anttila^1,3, Kristiina Pälve^1,3

¹Heart Center, Turku University Hospital, Turku, Finland.

|January 9, 2025

概括

在接受心脏手术的患者中,预防性静脉注射铁 (铁性碳酸) 并没有减少输血或感染. 然而,它是安全的,可能会减少手术后的再入院.

科学领域:

心脏病学心脏病学
血液学血液学血液学
手术医学手术医学

背景情况:

手术后贫血,输血和感染是手术中常见的并发症.
补充铁是一种减轻这些风险的潜在策略.
预防性静脉注射铁在非贫血心脏手术患者中的作用需要调查.

研究的目的:

评估预防性静脉注射铁补充剂的疗效和安全性.
评估其对接受心脏手术而没有贫血的患者输血和感染的影响.

主要方法:

一个随机的,双盲的,安慰剂控制的试验.
接受重大心脏手术的患者在手术前2至21天接受铁性碳酸 (FCM) 或安慰剂.
主要终点:医院内输血 (>2单位) 和医院感染的组合.

主要成果:

审判因为徒劳而提前停止.
在FCM和安慰剂组之间的初级终点没有显著差异 (7.7%与7.7%,P=1.00).
后期分析显示,FCM组的再入院患者较少 (2.6%对20.5%,P=0.028).

结论:

预防性铁性碳酸盐对于接受心脏手术的非贫血患者是安全的.
它不会减少在指数住院期间需要输血或术后感染的需要.
进一步的研究可能会探索其潜在的益处,以减少长期再接收.

关键词:

大动脉门更换术冠状动脉旁路手术是什么意思补充铁补充剂补充铁补充剂 mitrale 门手术手术带门手术

更多相关视频

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

相关概念视频

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...